If you’re suffering with pain, fatigue, and fibro fog, relief is just a form fill away. Start your $49 trial to start feeling better in just 3 weeks. After that, continue our personalized cortisone treatment to reclaim your life for the long term.
From sleepless nights and fatigue to chronic pain—fibromyalgia takes a true toll on your quality of life. If enough is enough, it’s time to take the first step toward lasting relief.
Microdose Therapy™ harnesses the power of cortisol to help provide effective treatment for inflammation and chronic pain. With small doses on the bad days and no doses on the good days, Microdose Therapy™ puts you in control of pain management, with education and ongoing support every step of the way.
“It used to be that I couldn’t get out of a chair without my husband’s help. Microdose Therapy™ has given me my life back. I’m able to walk and stand up straight. I can ride my bicycle and go hiking again.”
Kay A, fibromyalgia patient
77% symptom relief
from fibromyalgia
in just three weeks.
With no significant side effects.*
“After using Microdose Therapy™ for over two years, 80% of my patients experienced dramatic relief. The Microdose system gives control to the patient in treating their disease.”
RJ Koval, M.D., Family Practice
Your body produces cortisol, a naturally occurring hormone, to manage pain, but inflammatory and autoimmune diseases weaken the body’s ability to produce it. That’s where cortisone, cortisol’s synthetic counterpart, comes into play.
Microdose Therapy™ ensures the body has just the right dosage of cortisone treatment to stave off chronic pain and inflammation without the risk of adverse side effects.
Don’t suffer through painful inflammation and fibromyalgia symptoms any longer. Just fill out the form, and our specialists will show you how you can get started with Microdose Therapy™ for just $49.
Professor Virgil Stenberg, Founder
The Helen Foundation is dedicated to improving lives through the cutting-edge science of Microdose Therapy™, offering proven relief for individuals living with moderate to severe arthritis, fibromyalgia, and other inflammatory diseases. Our treatment has helped more than 2,600 patients reduce their symptoms by an incredible 76% on average, as supported by a 2019 study in the Journal of Inflammation Research.
References:
*Based on a published 2019 study of 601 patients diagnosed with fibromyalgia; with training, participants maintained improvements over time with no significant side effects. https://www.tandfonline.com/doi/full/10.2147/JIR.S195165